Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical roflumilast in atopic dermatitis
NCT01856764Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2013
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of roflumilast vehicle cream in atopic dermatitis (AD) (2 arms), sponsored by AstraZeneca. Primary endpoint: Change From Baseline to Day 15 in Modified Local SCORing Atopic Dermatitis. Started Jun 2013; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01856764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856764.